Navigation Links
Par Pharmaceutical To Acquire Anchen Pharmaceuticals
Date:8/24/2011

by JKF Advisors LLC, Orrick, Herrington & Sutcliffe LLP, and Arent Fox LLP, PricewaterhouseCoopers LLP, among others.  In addition, the Company received a fairness opinion from J.P. Morgan in connection with the transaction.

Anchen Pharmaceuticals was advised by Jefferies & Company and Winston & Strawn LLP.

Conference CallThe Company will host a conference call and webcast to discuss the transaction today at 10:00a.m. Eastern Daylight Time.  Access to the live webcast can be made via the Company's website at www.parpharm.com.Dial-in InformationDomestic:

866-783-2140International:

857-350-1599Passcode:

81836190A replay of the conference call will be available for two weeks approximately one hour after the call.  

Replay InformationDomestic:

888-286-8010International:

617-801-6888Passcode:

17442854About Par Pharmaceutical Companies, Inc.Par Pharmaceutical Companies, Inc. is a US-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.

Safe Harbor StatementCertain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward-looking and, as such, are subject to known and unknown risks, uncertainties and contingencies, many of which are beyond the control of the Company, which could cause actual results and outcomes to differ materially from those expressed herein.  Ri
'/>"/>

SOURCE Par Pharmaceutical Companies
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference
2. Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid
3. KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema
4. Mainor Eglet Attorney, Robert Eglet, Calls Teva Pharmaceuticals Vice President Craig Lea to the Stand in Hepatitis C Trial
5. Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President
6. Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients
7. Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
8. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
9. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
10. Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol
11. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 CEFALY Technology ... nerve stimulation device specifically authorized for use prior to ... from a new PET trial showing that the Cefaly ... the brain in migraine patients, namely the orbitofrontal cortex ... (PET) scan, which is an imaging test of the brain, used a ...
(Date:6/1/2015)... 2015 NSHOA Cancer Center and Heron ... positive, top-line results from its recently completed Phase ... safety of the Company,s 5-HT 3 receptor ... extended release) as part of a three-drug regimen ... receptor antagonist fosaprepitant and the IV corticosteroid dexamethasone ...
(Date:6/1/2015)... YORK , June 1, 2015   ... of Open, Transparent and Connected financial marketplaces for ... Incorporated, a San Diego -based ... traded on OTCQB®, America,s only public venture market ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ...
Breaking Medicine Technology:New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2New cancer therapy study results - MAGIC Trial 2OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... SAN DIEGO, Aug. 16, 2011 Optimer Pharmaceuticals, Inc. ... subgroup analysis of patients receiving concomitant systemic antibiotics in ... DIFICID™ (fidaxomicin) tablets in the treatment of adult patients ... online in the September 1 issue of Clinical ...
... 16, 2011 CVS/pharmacy announced today that all ... Compliance Corp.,s Environmental Return System, which provides customers ... unused, expired or unwanted drugs using affordable medication ... The postage-paid envelopes cost $3.99 and allow customers ...
Cached Medicine Technology:Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 2Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 3Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 4Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 5Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 6CVS/pharmacy Offers Customers Safe Disposal Program for Medications 2CVS/pharmacy Offers Customers Safe Disposal Program for Medications 3
(Date:6/1/2015)... Linda Kincaid, age 67, knew something was wrong. She ... she thought it was just a part of getting older, ... that. After going to the doctor, she received a distressing ... what might happen to her. , Linda is not alone. ... disease each year. Valve disease involves damage to one or ...
(Date:6/1/2015)... 2015 Cambia Health Solutions and ... new, interactive Affordable Care Act (ACA) training course ... called “Affordable Care Act Expert Series, Large Group ... and consultative insights necessary to effectively engage and ... impacts of the ACA. , The interactive, experience-based ...
(Date:6/1/2015)... New York, NY (PRWEB) June 01, 2015 ... largely by patients requesting celebrity features. Much like one ... their favorite stars’ noses, eyes, cheeks, chin and more ... other photo filtering apps like FaceTune are ushering in ... , Top Manhattan facial plastic surgeon, Sam Rizk, MD, ...
(Date:6/1/2015)... 01, 2015 Listen to Volvo’s Director ... companies are using more granular data to create better ... new industry voices in Josep Celaya Gonzalez, CIO at ... ParkTAG. As an automotive insurer, MAPFRE are well versed ... easy-to-use solution to the driver. Award winning start-up ParkTAG ...
(Date:6/1/2015)... 2015 A University of Texas ... signaling proteins that activate protein degradation, which helps ... 1 , The study published April 3rd ... Spraque-Dawley rats 2-3 months of age who performed ... given either whey protein (.4g/kg), low-dose Sustamine (.1g/kg), ...
Breaking Medicine News(10 mins):Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Instagram Filters Launch New Facial Plastic Surgery Trend 2Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 3
... a tribal-dominated Orissa district in the past fortnight, say ... district. The victims contracted the disease after eating rotten buffalo ... and Sirimunda village, some 500 km from here, died of ... succumbed later, chief district medical officer K. Haribandhu Reddy told ...
... after a strong earthquake with a magnitude of 6.4 ... ,The quake shook the old downtown area of ... 5:34 a.m., with the epicentre at 23 degrees north and ... ,The quake also forced the evacuation of 120,000 residents, ...
... smoking in enclosed public spaces comes into force in the ... who might despair help is at hand. ,A ... the green light by the National Institute for Health and ... it should supply. ,The pill, taken twice a ...
... a retrospective study of 700 patients with culture-positive ... significantly higher in HIV-infected patients compared to ... relapse rates were higher in HIV-infected patients who ... to those receiving daily or longer treatment. ...
... University of Illinois Medical Center at Chicago performed a ... relieve him of debilitating pain. They also performed an ... surgical diabetes. ,Terry Near, of Rock Falls, ... undergo a pancreatectomy, or removal of the pancreas, using ...
... urging the developing world to look for new initiatives and ... services. But many nations in the African continent are hard ... ,Like elsewhere in the third world, visitors ... Lusaka hundreds of persons walking aimlessly along the roads, talking ...
Cached Medicine News:Health News:New Drug to Help Kick Smoking Habit Cleared in UK 2Health News:New Drug to Help Kick Smoking Habit Cleared in UK 3Health News:Treatment Outcomes of Patients With HIV and Tuberculosis 2Health News:First-Ever Robotic Pancreatectomy Performed at UIC 2Health News:Zambia Trying Hard to Tackle Crisis in Mental Health Care 2
... with 3 charging wells. Available In 4 ... and Cinnamon. Spring balanced refractor and slit ... construction for lifelong quality. Sealed hydraulic system ... movement. Chair back reclines manually to fully ...
... the patented HydroKeratome corneal cutting device for ... industry experts believe it will replace the ... used in the LASIK refractive procedure. In ... has demonstrated that its proprietary technology is ...
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Coaxial Ophthalmoscope Set with Convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Medicine Products: